{
    "2020-06-06": [
        [
            {
                "time": "2023-10-05",
                "original_text": "If You Like Dividends, You Should Love These 2 Stocks",
                "features": {
                    "keywords": [
                        "dividends",
                        "stocks"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "finance"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "AbbVie Presents Data Showing RINVOQâ„¢ (upadacitinib) Meets Primary and Key Secondary Endpoints in Phase 3 Head-to-Head Study Versus ORENCIA (abatacept) in Rheumatoid Arthritis Patients",
                "features": {
                    "keywords": [
                        "AbbVie",
                        "RINVOQ",
                        "Phase 3",
                        "Endpoints",
                        "ORENCIA",
                        "Rheumatoid Arthritis"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}